Selective Laser Sintering 3D Printing of Orally Disintegrating Printlets Containing Ondansetron
Tóm tắt
The aim of this work was to explore the feasibility of using selective laser sintering (SLS) 3D printing (3DP) to fabricate orodispersable printlets (ODPs) containing ondansetron. Ondansetron was first incorporated into drug-cyclodextrin complexes and then combined with the filler mannitol. Two 3D printed formulations with different levels of mannitol were prepared and tested, and a commercial ondansetron orally disintegrating tablet (ODT) product (Vonau® Flash) was also investigated for comparison. Both 3D printed formulations disintegrated at ~15 s and released more than 90% of the drug within 5 min independent of the mannitol content; these results were comparable to those obtained with the commercial product. This work demonstrates the potential of SLS 3DP to fabricate orodispersible printlets with characteristics similar to a commercial ODT, but with the added benefit of using a manufacturing technology able to prepare medicines individualized to the patient.
Từ khóa
Tài liệu tham khảo
World Health Organization (WHO) (2020, January 21). The selection and use of essential medicines: Report of the who expert committee. Available online: http://apps.who.int/iris/bitstream/10665/189763/1/9789241209946_eng.pdf.
Sheshala, 2011, Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants, Arch. Pharmacal Res., 34, 1945, 10.1007/s12272-011-1115-y
Bhoyar, 2010, Formulation and characterization of patient-friendly dosage form of ondansetron hydrochloride, J Young Pharm, 2, 240, 10.4103/0975-1483.66796
Goel, 2009, Understanding the mechanism for paradoxical effect of ionized and unionized chitosan: Orodispersible tablets of ondansetron hydrochloride, Pharm. Dev. Technol., 14, 476, 10.1080/10837450902749279
Khan, 2007, Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets, AAPS PharmSciTech, 8, E127, 10.1208/pt0802046
2010, Cyclodextrins in drug delivery systems, J. Drug Deliv. Sci. Tec., 20, 289, 10.1016/S1773-2247(10)50046-7
Jansook, 2018, Cyclodextrins: Structure, physicochemical properties and pharmaceutical applications, Int. J. Pharm., 535, 272, 10.1016/j.ijpharm.2017.11.018
2004, Cyclodextrins and their uses: A review, Process Biochemistry, 39, 1033, 10.1016/S0032-9592(03)00258-9
Charbit, 2008, Droperidol and ondansetron-induced QT interval prolongation: A clinical drug interaction study, Anesthesiol. J. Am. Soc. Anesthesiol., 109, 206
Goyanes, 2019, Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients, Int. J. Pharm., 567, 118497, 10.1016/j.ijpharm.2019.118497
Trenfield, 2018, 3D printing pharmaceuticals: Drug development to frontline care, Trends Pharmacol. Sci., 39, 440, 10.1016/j.tips.2018.02.006
Araújo, M.R.P., Sa-Barreto, L.L., Gratieri, T., Gelfuso, G.M., and Cunha-Filho, M. (2019). The digital pharmacies era: How 3D printing technology using fused deposition modeling can become a reality. Pharmaceutics, 11.
Zema, 2017, Three-dimensional printing of medicinal products and the challenge of personalized therapy, J. Pharm. Sci., 106, 1697, 10.1016/j.xphs.2017.03.021
Sadia, 2016, Adaptation of pharmaceutical excipients to fdm 3D printing for the fabrication of patient-tailored immediate release tablets, Int. J. Pharm., 513, 659, 10.1016/j.ijpharm.2016.09.050
Alhnan, 2016, Emergence of 3D printed dosage forms: Opportunities and challenges, Pharm. Res., 33, 1817, 10.1007/s11095-016-1933-1
Awad, 2018, Reshaping drug development using 3D printing, Drug Discov. Today, 23, 1547, 10.1016/j.drudis.2018.05.025
Trenfield, 2019, Shaping the future: Recent advances of 3D printing in drug delivery and healthcare, Expert Opin. Drug Deliv., 16, 1081, 10.1080/17425247.2019.1660318
Gioumouxouzis, 2019, Recent advances in pharmaceutical dosage forms and devices using additive manufacturing technologies, Drug Discov. Today, 24, 636, 10.1016/j.drudis.2018.11.019
Markl, 2017, Analysis of 3D prints by x-ray computed microtomography and terahertz pulsed imaging, Pharm. Res., 34, 1037, 10.1007/s11095-016-2083-1
Genina, 2017, Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing, J. Control. Release., 268, 40, 10.1016/j.jconrel.2017.10.003
Trenfield, 2019, Track-and-trace: Novel anti-counterfeit measures for 3D printed personalized drug products using smart material inks, Int. J. Pharm., 567, 118443, 10.1016/j.ijpharm.2019.06.034
Sadia, 2018, Channelled tablets: An innovative approach to accelerating drug release from 3D printed tablets, J. Control. Release., 269, 355, 10.1016/j.jconrel.2017.11.022
Beck, 2017, 3D printed tablets loaded with polymeric nanocapsules: An innovative approach to produce customized drug delivery systems, Int. J. Pharm., 528, 268, 10.1016/j.ijpharm.2017.05.074
Gioumouxouzis, 2017, 3D printed oral solid dosage forms containing hydrochlorothiazide for controlled drug delivery, J. Drug Deliv. Sci. Tec., 40, 164, 10.1016/j.jddst.2017.06.008
Goyanes, 2017, Patient acceptability of 3D printed medicines, Int. J. Pharm., 530, 71, 10.1016/j.ijpharm.2017.07.064
Kollamaram, 2018, Low temperature fused deposition modeling (fdm) 3D printing of thermolabile drugs, Int. J. Pharm., 545, 144, 10.1016/j.ijpharm.2018.04.055
Zhang, 2019, 3D-printed isoniazid tablets for the treatment and prevention of tuberculosis—personalized dosing and drug release, AAPS Pharmscitech, 20, 52, 10.1208/s12249-018-1233-7
Khaled, 2015, 3D printing of tablets containing multiple drugs with defined release profiles, Int. J. Pharm., 494, 643, 10.1016/j.ijpharm.2015.07.067
Khaled, 2014, Desktop 3D printing of controlled release pharmaceutical bilayer tablets, Int. J. Pharm., 461, 105, 10.1016/j.ijpharm.2013.11.021
Vithani, 2019, A proof of concept for 3D printing of solid lipid-based formulations of poorly water-soluble drugs to control formulation dispersion kinetics, Pharm. Res., 36, 102, 10.1007/s11095-019-2639-y
Vithani, 2019, An overview of 3D printing technologies for soft materials and potential opportunities for lipid-based drug delivery systems, Pharm. Res., 36, 4, 10.1007/s11095-018-2531-1
Linares, 2019, Printfills: 3D printed systems combining fused deposition modeling and injection volume filling. Application to colon-specific drug delivery, Eur. J. Pharm. Biopharm., 134, 138, 10.1016/j.ejpb.2018.11.021
Goyanes, 2019, Hydroxypropyl-β-cyclodextrin-based fast dissolving carbamazepine printlets prepared by semisolid extrusion 3D printing, Carbohydr. Polym., 221, 55, 10.1016/j.carbpol.2019.05.084
Goyanes, 2019, Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process, Int. J. Pharm., 567, 118471, 10.1016/j.ijpharm.2019.118471
Basit, A.W., and Gaisford, S. (2018). 3D printing technologies, implementation and regulation: An overview. 3D printing of pharmaceuticals, Springer International Publishing.
Healy, A.V., Fuenmayor, E., Doran, P., Geever, L.M., Higginbotham, C.L., and Lyons, J.G. (2019). Additive manufacturing of personalized pharmaceutical dosage forms via stereolithography. Pharmaceutics, 11.
Robles-Martinez, P., Xu, X., Trenfield, S.J., Awad, A., Goyanes, A., Telford, R., Basit, A.W., and Gaisford, S. (2019). 3D printing of a multi-layered polypill containing six drugs using a novel stereolithographic method. Pharmaceutics, 11.
Xu, X., Robles-Martinez, P., Madla, C.M., Goyanes, A., Joubert, F., Basit, A.W., and Gaisford, S. (2020). Stereolithography (SLA) 3D printing of an antihypertensive polyprintlet: Case study of an unexpected photopolymer-drug reaction. Addit. Manuf., 101071.
Basit, A.W., and Gaisford, S. (2018). Powder bed fusion: The working process, current applications and opportunities. 3D printing of pharmaceuticals, Springer International Publishing.
Yuan, 2019, Polymeric composites for powder-based additive manufacturing: Materials and applications, Prog. Polym. Sci, 91, 141, 10.1016/j.progpolymsci.2018.11.001
Fina, 2017, Selective laser sintering (SLS) 3D printing of medicines, Int. J. Pharm., 529, 285, 10.1016/j.ijpharm.2017.06.082
Mohamed, 2019, Understanding the effects of formulation and process variables on the printlets quality manufactured by selective laser sintering 3D printing, Int. J. Pharm., 570, 118651, 10.1016/j.ijpharm.2019.118651
Awad, A., Fina, F., Trenfield, S.J., Patel, P., Goyanes, A., Gaisford, S., and Basit, A.W. (2019). 3D printed pellets (miniprintlets): A novel, multi-drug, controlled release platform technology. Pharmaceutics, 11.
Fina, 2018, 3D printing of drug-loaded gyroid lattices using selective laser sintering, Int. J. Pharm., 547, 44, 10.1016/j.ijpharm.2018.05.044
Cheah, 2002, Characterization of microfeatures in selective laser sintered drug delivery devices, Proc. Inst. Mech. Eng. Part H J. Eng. Med., 216, 369, 10.1243/095441102321032166
Trenfield, 2018, 3D printed drug products: Non-destructive dose verification using a rapid point-and-shoot approach, Int. J. Pharm., 549, 283, 10.1016/j.ijpharm.2018.08.002
Fina, 2018, Fabricating 3D printed orally disintegrating printlets using selective laser sintering, Int. J. Pharm., 541, 101, 10.1016/j.ijpharm.2018.02.015
(2016). European pharmacopoeia, European Directorate for the Quality of Medicines and Healthcare. [9th ed.].
CDER, F (2017, January 26). Guidance for Industry: Orally Disintegrating Tablets, Available online: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070578.pdf.
Parkash, 2011, Fast disintegrating tablets: Opportunity in drug delivery system, J. Adv. Pharm. Technol. Res., 2, 223, 10.4103/2231-4040.90877
Draskovic, 2017, In vitro and in vivo investigation of taste-masking effectiveness of eudragit E PO as drug particle coating agent in orally disintegrating tablets, Drug Dev. Ind. Pharm., 43, 723, 10.1080/03639045.2016.1220572
Nagar, 2011, Orally disintegrating tablets: Formulation, preparation techniques and evaluation, J. Appl. Pharm. Sci., 1, 35
Aslani, 2016, Design, formulation, and physicochemical evaluation of montelukast orally disintegrating tablet, Int. J. Prev. Med., 7, 120, 10.4103/2008-7802.193097
Trenfield, S.J., Xian Tan, H., Goyanes, A., Wilsdon, D., Rowland, M., Gaisford, S., and Basit, A.W. (2020). Non-destructive dose verification of two drugs within 3D printed polyprintlets. Int. J. Pharm., 119066.
(2019). USP 42 - NF 37 The United States Pharmacopeia and National Formulary 2019, United States Pharmacopeial Convention Inc.
Kolter, K., Karl, M., Gryczke, A., and Ludwigshafen am Rhein, B. (2012). Hot-melt Extrusion with BASF Pharma Polymers: Extrusion Compendium, BASF.
Sahoo, 2015, A review on controlled porosity osmotic pump tablets and its evaluation, Bull. Fac. Pharm. Cairo Univ., 53, 195
Aprecia_Pharmaceuticals (2020, January 26). FDA Approves the First 3D Printed Drug Product. Available online: http://www.multivu.com/players/English/7577251-aprecia-pharmaceuticals-spritam/.